India · Delayed Price · Currency is INR Lincoln Pharmaceuticals Statistics
Total Valuation
BOM:531633 has a market cap or net worth of INR 9.08 billion. The enterprise value is 6.76 billion.
| Market Cap | 9.08B |
| Enterprise Value | 6.76B |
Important Dates
The next estimated earnings date is Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | Sep 12, 2025 |
Share Statistics
BOM:531633 has 20.03 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 20.03M |
| Shares Outstanding | 20.03M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 49.15% |
| Owned by Institutions (%) | 1.74% |
| Float | 9.05M |
Valuation Ratios
The trailing PE ratio is 11.35.
| PE Ratio | 11.35 |
| Forward PE | n/a |
| PS Ratio | 1.44 |
| PB Ratio | 1.27 |
| P/TBV Ratio | 1.27 |
| P/FCF Ratio | 11.56 |
| P/OCF Ratio | 9.04 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.71, with an EV/FCF ratio of 8.61.
| EV / Earnings | 8.45 |
| EV / Sales | 1.07 |
| EV / EBITDA | 6.71 |
| EV / EBIT | 7.75 |
| EV / FCF | 8.61 |
Financial Position
The company has a current ratio of 4.71, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.71 |
| Quick Ratio | 3.46 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.00 |
| Interest Coverage | 134.52 |
Financial Efficiency
Return on equity (ROE) is 11.81% and return on invested capital (ROIC) is 13.33%.
| Return on Equity (ROE) | 11.81% |
| Return on Assets (ROA) | 6.67% |
| Return on Invested Capital (ROIC) | 13.33% |
| Return on Capital Employed (ROCE) | 11.81% |
| Weighted Average Cost of Capital (WACC) | 5.17% |
| Revenue Per Employee | 3.41M |
| Profits Per Employee | 431,752 |
| Employee Count | 1,853 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 3.63 |
Taxes
In the past 12 months, BOM:531633 has paid 291.24 million in taxes.
| Income Tax | 291.24M |
| Effective Tax Rate | 26.69% |
Stock Price Statistics
The stock price has decreased by -38.38% in the last 52 weeks. The beta is 0.16, so BOM:531633's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | -38.38% |
| 50-Day Moving Average | 491.14 |
| 200-Day Moving Average | 538.07 |
| Relative Strength Index (RSI) | 35.38 |
| Average Volume (20 Days) | 719 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:531633 had revenue of INR 6.32 billion and earned 800.04 million in profits. Earnings per share was 39.94.
| Revenue | 6.32B |
| Gross Profit | 3.32B |
| Operating Income | 872.12M |
| Pretax Income | 1.09B |
| Net Income | 800.04M |
| EBITDA | 1.01B |
| EBIT | 872.12M |
| Earnings Per Share (EPS) | 39.94 |
Balance Sheet
The company has 2.32 billion in cash and 668,000 in debt, with a net cash position of 2.32 billion or 115.75 per share.
| Cash & Cash Equivalents | 2.32B |
| Total Debt | 668,000 |
| Net Cash | 2.32B |
| Net Cash Per Share | 115.75 |
| Equity (Book Value) | 7.16B |
| Book Value Per Share | 357.45 |
| Working Capital | 4.30B |
Cash Flow
In the last 12 months, operating cash flow was 1.00 billion and capital expenditures -219.13 million, giving a free cash flow of 785.44 million.
| Operating Cash Flow | 1.00B |
| Capital Expenditures | -219.13M |
| Free Cash Flow | 785.44M |
| FCF Per Share | 39.21 |
Margins
Gross margin is 52.44%, with operating and profit margins of 13.80% and 12.66%.
| Gross Margin | 52.44% |
| Operating Margin | 13.80% |
| Pretax Margin | 17.26% |
| Profit Margin | 12.66% |
| EBITDA Margin | 15.92% |
| EBIT Margin | 13.80% |
| FCF Margin | 12.42% |
Dividends & Yields
This stock pays an annual dividend of 1.80, which amounts to a dividend yield of 0.39%.
| Dividend Per Share | 1.80 |
| Dividend Yield | 0.39% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 4.48% |
| Buyback Yield | 0.01% |
| Shareholder Yield | 0.41% |
| Earnings Yield | 8.81% |
| FCF Yield | 8.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 19, 2009. It was a reverse split with a ratio of 0.2.
| Last Split Date | Mar 19, 2009 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |